Skip to main content
Clinical Trials/NCT04451798
NCT04451798
Recruiting
Not Applicable

JENA Mechanical Assist Circulatory Support Trial-JENAMACS-hemodynamic

University of Leipzig1 site in 1 country20 target enrollmentDecember 2016

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Cardiogenic Shock
Sponsor
University of Leipzig
Enrollment
20
Locations
1
Primary Endpoint
Hemodynamic Parameters due to PA catheterisation
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

Prospective, monocentric open-label observational study for the assessment of acute hemodynamic effects following implantation of the IMPELLA CP cardiac support device

Registry
clinicaltrials.gov
Start Date
December 2016
End Date
March 2023
Last Updated
3 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
University of Leipzig
Responsible Party
Principal Investigator
Principal Investigator

Sven Möbius-Winkler

Principal Investigator, Clinical Professor

University of Leipzig

Eligibility Criteria

Inclusion Criteria

  • Cardiogenic shock following acute MI or acute heart failure with
  • systolic BP \< 90 mm Hg over \> 30 min or inotropes for support of cardiac output and BP with
  • signs of left heart failure and pulmonary congestion
  • and end-organ hypo perfusion with somnolence or cold, pale skin, or oliguria or serum lactate \>2 mmol/l

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Hemodynamic Parameters due to PA catheterisation

Time Frame: Day 1

Pulmonary capillary Wedge pressure in dependence of Impella pump level

Echocardiographic Parameters of left and right heart function

Time Frame: Day 1

LV- size in dependence of Impella pump level

Study Sites (1)

Loading locations...

Similar Trials